HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Ruts, L. Articles by van Doorn, P. A. Search for Related Content PubMed PubMed Citation Articles by Ruts, L. Articles by van Doorn, P. A. Related Collections Peripheral neuropathy Guillain-Barre syndrome Chronic inflammatory demyelinating polyneuropathy

Distinguishing acute-onset CIDP from Guillain–Barré syndrome with treatment related fluctuations

From the Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.

Address correspondence and reprint requests to Dr. Liselotte Ruts, Erasmus MC (Faculty), Department of Neurology, Room Ee-2230, PO Box 1738, 3000 DR Rotterdam, The Netherlands; e-mail: l.ruts{at}erasmusmc.nl

Guillain–Barré syndrome (GBS) patients may worsen after initial treatment (treatment-related fluctuation [TRF]). It is difficult to distinguish GBS-TRF from chronic inflammatory demyelinating polyneuropathy with acute onset (A-CIDP). The authors compared 13 patients with A-CIDP with 11 patients with GBS-TRF and concluded that A-CIDP should be suspected when a patient with GBS deteriorates after 9 weeks from onset or when deterioration occurs three times or more. Maintenance treatment should then be considered.

Received December 16, 2004. Accepted in final form March 28, 2005.